Depreciation of Jazz Pharmaceuticals plc from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Jazz Pharmaceuticals plc annual and quarterly Depreciation in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Jazz Pharmaceuticals plc Depreciation for the quarter ending 31 Mar 2025 was $10,425,000, a 36% increase year-over-year.
  • Jazz Pharmaceuticals plc annual Depreciation for 2025 was $41,636,000, a 27% increase from 2024.
  • Jazz Pharmaceuticals plc annual Depreciation for 2024 was $32,754,000, a 7.7% increase from 2023.
  • Jazz Pharmaceuticals plc annual Depreciation for 2023 was $30,412,000, a 0.36% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Jazz Pharmaceuticals plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $41,636,000 +$8,882,000 +27% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $32,754,000 +$2,342,000 +7.7% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $30,412,000 +$110,000 +0.36% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $30,302,000 +$3,588,000 +13% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $26,714,000 +$8,041,000 +43% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $18,673,000 +$3,331,000 +22% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $15,342,000 +$109,000 +0.72% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $15,233,000 +$2,144,000 +16% 01 Jan 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
2017 $13,089,000 +$1,303,000 +11% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $11,786,000 +$1,892,000 +19% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $9,894,000 +$2,797,000 +39% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $7,097,000 +$4,049,000 +133% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $3,048,000 +$1,741,000 +133% 01 Jan 2013 31 Dec 2013 10-K 23 Feb 2016 2015 FY
2012 $1,307,000 +$928,000 +245% 01 Jan 2012 31 Dec 2012 10-K 24 Feb 2015 2014 FY
2011 $379,000 -$507,000 -57% 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014 2013 FY
2010 $886,000 01 Jan 2010 31 Dec 2010 10-K 26 Feb 2013 2012 FY

Jazz Pharmaceuticals plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $10,425,000 +$2,772,000 +36% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $7,653,000 +$79,000 +1% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $7,574,000 -$43,000 -0.56% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $7,617,000 +$2,838,000 +59% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $4,779,000 +$252,000 +5.6% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $4,527,000 +$988,000 +28% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $3,539,000 -$183,000 -4.9% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q1 2018 $3,722,000 +$592,000 +19% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $3,130,000 +$603,000 +24% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $2,527,000 +$295,000 +13% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $2,232,000 +$923,000 +71% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $1,309,000 +$734,000 +128% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $575,000 +$389,000 +209% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $186,000 +$82,000 +79% 01 Jan 2012 31 Mar 2012 10-Q 07 May 2013 2013 Q1
Q1 2011 $104,000 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.